Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 21,5x - 23,8x | 22,7x |
| Selected Fwd EBIT Multiple | 12,0x - 13,3x | 12,7x |
| Fair Value | ₹560,71 - ₹625,47 | ₹593,09 |
| Upside | -14,8% - -4,9% | -9,9% |
| Benchmarks | Ticker | Full Ticker |
| Anuh Pharma Limited | 506260 | BSE:506260 |
| Solara Active Pharma Sciences Limited | 541540 | BSE:541540 |
| Vasundhara Rasayans Limited | 538634 | BSE:538634 |
| Suven Pharmaceuticals Limited | 543064 | BSE:543064 |
| Supriya Lifescience Limited | 543434 | BSE:543434 |
| Shilpa Medicare Limited | 530549 | BSE:530549 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 506260 | 541540 | 538634 | 543064 | 543434 | 530549 | ||
| BSE:506260 | BSE:541540 | BSE:538634 | BSE:543064 | BSE:543434 | BSE:530549 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 15.5% | NM- | 41.5% | -1.9% | 19.4% | 2.8% | |
| 3Y CAGR | 31.3% | NM- | 26.9% | -4.7% | -1.2% | 2.8% | |
| Latest Twelve Months | -15.7% | 145.9% | 39.6% | -31.0% | 48.1% | 105.9% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 8.0% | 2.5% | 13.2% | 38.3% | 32.5% | 10.8% | |
| Prior Fiscal Year | 8.3% | 1.9% | 14.3% | 39.3% | 25.4% | -0.5% | |
| Latest Fiscal Year | 10.3% | -15.3% | 17.1% | 33.7% | 28.1% | 11.2% | |
| Latest Twelve Months | 8.5% | 5.5% | 16.8% | 29.6% | 34.8% | 15.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.13x | 2.52x | 1.94x | 27.41x | 8.69x | 4.98x | |
| EV / LTM EBITDA | 11.6x | 19.7x | 10.9x | 78.5x | 23.2x | 20.2x | |
| EV / LTM EBIT | 13.2x | 46.2x | 11.5x | 92.6x | 25.0x | 32.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 11.5x | 25.0x | 92.6x | ||||
| Historical EV / LTM EBIT | 13.3x | 51.9x | 65.0x | ||||
| Selected EV / LTM EBIT | 21.5x | 22.7x | 23.8x | ||||
| (x) LTM EBIT | 1,921 | 1,921 | 1,921 | ||||
| (=) Implied Enterprise Value | 41,389 | 43,567 | 45,745 | ||||
| (-) Non-shareholder Claims * | (4,734) | (4,734) | (4,734) | ||||
| (=) Equity Value | 36,654 | 38,833 | 41,011 | ||||
| (/) Shares Outstanding | 86.8 | 86.8 | 86.8 | ||||
| Implied Value Range | 422.28 | 447.37 | 472.47 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 422.28 | 447.37 | 472.47 | 657.90 | |||
| Upside / (Downside) | -35.8% | -32.0% | -28.2% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 506260 | 541540 | 538634 | 543064 | 543434 | 530549 | |
| Enterprise Value | 7,309 | 32,925 | 745 | 267,366 | 58,154 | 61,841 | |
| (+) Cash & Short Term Investments | 519 | 61 | 17 | 6,559 | 843 | 172 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (141) | (8,400) | (9) | (395) | (55) | (4,906) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,687 | 24,586 | 753 | 273,530 | 58,942 | 57,107 | |
| (/) Shares Outstanding | 50.1 | 48.1 | 3.2 | 254.6 | 80.5 | 86.8 | |
| Implied Stock Price | 153.40 | 511.65 | 237.00 | 1,074.50 | 732.35 | 657.90 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 153.40 | 511.65 | 237.00 | 1,074.50 | 732.35 | 657.90 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |